Your search returned 7 results.

Results
	1.	To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? [electronic resource] by van de Loo-Neus, Gigi H H Rommelse, Nanda Buitelaar, Jan K Producer: 20111128 In: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Atomoxetine in autism spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change. [electronic resource] by Harfterkamp, Myriam Buitelaar, Jan K Minderaa, Ruud B van de Loo-Neus, Gigi van der Gaag, Rutger-Jan Hoekstra, Pieter J Producer: 20150917 In: Journal of child and adolescent psychopharmacology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study. [electronic resource] by Harfterkamp, Myriam Buitelaar, Jan K Minderaa, Ruud B van de Loo-Neus, Gigi van der Gaag, Rutger-Jan Hoekstra, Pieter J Producer: 20131209 In: Journal of child and adolescent psychopharmacology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. [electronic resource] by Harfterkamp, Myriam van de Loo-Neus, Gigi Minderaa, Ruud B van der Gaag, Rutger-Jan Escobar, Rodrigo Schacht, Alexander Pamulapati, Sireesha Buitelaar, Jan K Hoekstra, Pieter J Producer: 20121204 In: Journal of the American Academy of Child and Adolescent Psychiatry vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study. [electronic resource] by Matthijssen, Anne-Flore M Dietrich, Andrea Bierens, Margreet Kleine Deters, Renee van de Loo-Neus, Gigi H H van den Hoofdakker, Barbara J Buitelaar, Jan K Hoekstra, Pieter J Producer: 20200320 In: The American journal of psychiatry vol. 176 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Effects of Discontinuing Methylphenidate on Strengths and Difficulties, Quality of Life and Parenting Stress. [electronic resource] by Matthijssen, Anne-Flore M Dietrich, Andrea Bierens, Margreet Kleine Deters, Renee van de Loo-Neus, Gigi H H van den Hoofdakker, Barbara J Buitelaar, Jan K Hoekstra, Pieter J Producer: 20210610 In: Journal of child and adolescent psychopharmacology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms. [electronic resource] by van der Meer, Jolanda M J Harfterkamp, Myriam van de Loo-Neus, Gigi Althaus, Monika de Ruiter, Saskia W Donders, A Rogier T de Sonneville, Leo M J Buitelaar, Jan K Hoekstra, Pieter J Rommelse, Nanda N J Producer: 20140915 In: Journal of clinical psychopharmacology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)